Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Mahaffey

Showing results (211-220 of 627) with videos related to

Pageof 63
Sort By:
European Journal of Preventive Cardiology|May 17, 2014
Cardiovascular events in acute coronary syndrome patients with peripheral arterial disease treated with ticagrelor compared with clopidogrel: Data from the PLATO TrialManesh R Patel, Richard C Becker, Daniel M Wojdyla, et al.
American Heart Journal|October 17, 2012
Antithrombotic therapy for atrial fibrillation and coronary artery disease in older patientsConnie N Hess, Samuel Broderick, Jonathan P Piccini, et al.
European Heart Journal|December 26, 2009
Prognostic utility of quantifying evolutionary ST-segment depression on early follow-up electrocardiogram in patients with non-ST-segment elevation acute coronary syndromesRaymond T Yan, Andrew T Yan, Kenneth W Mahaffey, et al.
European Heart Journal|December 5, 2013
Efficacy and safety of rivaroxaban compared with warfarin in patients with peripheral artery disease and non-valvular atrial fibrillation: insights from ROCKET AFWilliam Schuyler Jones, Anne S Hellkamp, Jonathan Halperin, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 29, 2015
Lessons Learned from EVOLVE for Planning of Future Randomized Trials in Patients on DialysisPatrick S Parfrey, Geoffrey A Block, Ricardo Correa-Rotter, et al.
European Heart Journal. Cardiovascular Imaging|May 10, 2020
Incremental value of diastolic stress test in identifying subclinical heart failure in patients with diabetes mellitusTomoko Nishi, Yukari Kobayashi, Jeffrey W Christle, et al.
Cardiology and Therapy|October 15, 2025
Digital Strategies for Recruitment to Improve Diversity and Inclusion in Prospective Cardiovascular Clinical ResearchSneha S Jain, Fatima Rodriguez, Marco V Perez, et al.
Journal of the American Heart Association|June 20, 2015
Meta-analysis of intracranial hemorrhage in acute coronary syndromes: incidence, predictors, and clinical outcomesKenneth W Mahaffey, Rebecca Hager, Daniel Wojdyla, et al.
Journal of the American College of Cardiology|October 3, 2006
A subgroup analysis of the impact of prerandomization antithrombin therapy on outcomes in the SYNERGY trial: enoxaparin versus unfractionated heparin in non-ST-segment elevation acute coronary syndromesMarc Cohen, Kenneth W Mahaffey, Karen Pieper, et al.
Journal of the American Heart Association|June 11, 2018
Therapeutic Strategies Following Major, Clinically Relevant Nonmajor, and Nuisance Bleeding in Atrial Fibrillation: Findings From ORBIT-AFEmily C O'Brien, DaJuanicia N Holmes, Laine Thomas, et al.
Pageof 63

Showing results (211-220 of 627) with videos related to

Sort By:
Pageof 63
European Journal of Preventive Cardiology|May 17, 2014
Cardiovascular events in acute coronary syndrome patients with peripheral arterial disease treated with ticagrelor compared with clopidogrel: Data from the PLATO TrialManesh R Patel, Richard C Becker, Daniel M Wojdyla, et al.
American Heart Journal|October 17, 2012
Antithrombotic therapy for atrial fibrillation and coronary artery disease in older patientsConnie N Hess, Samuel Broderick, Jonathan P Piccini, et al.
European Heart Journal|December 26, 2009
Prognostic utility of quantifying evolutionary ST-segment depression on early follow-up electrocardiogram in patients with non-ST-segment elevation acute coronary syndromesRaymond T Yan, Andrew T Yan, Kenneth W Mahaffey, et al.
European Heart Journal|December 5, 2013
Efficacy and safety of rivaroxaban compared with warfarin in patients with peripheral artery disease and non-valvular atrial fibrillation: insights from ROCKET AFWilliam Schuyler Jones, Anne S Hellkamp, Jonathan Halperin, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 29, 2015
Lessons Learned from EVOLVE for Planning of Future Randomized Trials in Patients on DialysisPatrick S Parfrey, Geoffrey A Block, Ricardo Correa-Rotter, et al.
European Heart Journal. Cardiovascular Imaging|May 10, 2020
Incremental value of diastolic stress test in identifying subclinical heart failure in patients with diabetes mellitusTomoko Nishi, Yukari Kobayashi, Jeffrey W Christle, et al.
Cardiology and Therapy|October 15, 2025
Digital Strategies for Recruitment to Improve Diversity and Inclusion in Prospective Cardiovascular Clinical ResearchSneha S Jain, Fatima Rodriguez, Marco V Perez, et al.
Journal of the American Heart Association|June 20, 2015
Meta-analysis of intracranial hemorrhage in acute coronary syndromes: incidence, predictors, and clinical outcomesKenneth W Mahaffey, Rebecca Hager, Daniel Wojdyla, et al.
Journal of the American College of Cardiology|October 3, 2006
A subgroup analysis of the impact of prerandomization antithrombin therapy on outcomes in the SYNERGY trial: enoxaparin versus unfractionated heparin in non-ST-segment elevation acute coronary syndromesMarc Cohen, Kenneth W Mahaffey, Karen Pieper, et al.
Journal of the American Heart Association|June 11, 2018
Therapeutic Strategies Following Major, Clinically Relevant Nonmajor, and Nuisance Bleeding in Atrial Fibrillation: Findings From ORBIT-AFEmily C O'Brien, DaJuanicia N Holmes, Laine Thomas, et al.
Pageof 63